Compliant Analysis of Patient Samples and Data

NCT04364503 · tracked via the Priya Life Science USA tracker

Sponsor

Sequenom, Inc.

Phase

Observational

Started

2018-03-17

Last updated

2026-07-21

Condition(s) studied

Pregnancy RelatedCancerInfectious Disease

Investigational drug(s) / intervention(s)

Multiple interventions depending on diagnostic test being run.

Multiple interventions depending on diagnostic test being run.: Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.

Study summary

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: * Arm 1 * All samples and data are de-identified and HIPAA compliant * Arm 2 * Subject is of scientific interest to the Sponsor or treating physician * Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected. Exclusion Criteria: * Arm 1 * Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development * Arm 2 * Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

Primary outcome measure(s)

Remnant samples and data for research and development — Retrospective and Prospective collection. Samples and data may be collected for up 12 months after enrollment.
Remnant samples and data for research and development
Sample and data collection from subjects of scientific interest — Prospective collection. Samples and data may be collected for up to 12 months after enrollment
Collect additional clinical data and samples if needed from subjects tested by LabCorp or an affiliate.

Trial sites (9)

Facility	City	Region
Labcorp	Los Angeles	California
Sequenom, Inc	San Diego	California
Labcorp - Monogram Biosciences	South San Francisco	California
Labcorp - Esoterix	Englewood	Colorado
Labcorp - Litholink	Itasca	Illinois
Labcorp - Omniseq	Buffalo	New York
Labcorp	Burlington	North Carolina
Labcorp - Cytogenetics	Research Triangle Park	North Carolina
Labcorp	Research Triangle Park	North Carolina

More Sequenom, Inc. trials in the USA

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix Recruiting

Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay Recruiting

Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy Recruiting

Non-Invasive Preeclampsia Screening and Biobank Recruiting

Other trials for the same condition

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy Recruiting

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) Recruiting

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare. Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04364503 on ClinicalTrials.gov ↗ ← All trials in the USA